In a post hoc analysis, there was strong evidence that solar keratosis was associated with future PDE5 inhibitor use (odds ratio = 1.28, 95% CI 1.23–1.34, p < 0.001), suggesting that men with higher sun exposure were more likely to become PDE5 inhibitor users. This evidence concerns the gene PDE5A and actinic keratosis.